Skip to content
drillr.ai
Sign up

ATOS

Atossa Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.52
−0.40%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue8.0K—17.0K23.0K8.0K
Gross Profit(8.0K)—(17.0K)(23.0K)(8.0K)
Operating Expenses
R&D Expense21.2M21.2M14.1M17.3M15.1M
SG&A Expense18.0M16.0M13.5M14.0M12.6M
General & Admin Expense18.0M16.0M13.5M14.0M12.6M
Selling & Marketing Expense(8.0K)————
Other Expenses—————
Total Operating Expenses39.2M37.1M27.6M31.4M27.7M
Cost and Expenses39.3M37.1M27.6M31.4M27.7M
Operating Income (EBIT)(39.3M)(37.1M)(27.6M)(31.4M)(27.7M)
Non-Operating
Interest Income1.5M2.4M4.0M4.3M877.0K
Interest Expense—————
Net Interest Income1.5M2.4M4.0M4.3M877.0K
Other Non-Op Income/Expense1.5M2.4M2.1M1.3M731.0K
Non-Operating Income (excl Interest)(1.5M)(2.4M)(2.1M)(1.3M)(731.0K)
EBT (Pre-Tax Income)(37.7M)(34.8M)(25.5M)(30.1M)(27.0M)
Income Tax Expense—————
Bottom Line
Net Income(37.7M)(34.8M)(25.5M)(30.1M)(27.0M)
Earnings from Cont. Ops(37.7M)(34.8M)(25.5M)(30.1M)(27.0M)
Earnings from Discont. Ops—————
Bottom Line Net Income(37.7M)(34.8M)(25.5M)(30.1M)(27.0M)
Per Share
Basic EPS($4.34)($4.04)($3.00)($3.60)($3.15)
Diluted EPS($4.34)($4.04)($3.00)($3.60)($3.15)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding8.9M8.6M8.4M8.4M8.4M
Diluted Shares Outstanding8.9M8.6M8.4M8.4M8.4M
Profitability Metrics
EBITDA(37.7M)(34.8M)(25.5M)(30.1M)(27.0M)
D&A16.0K16.0K17.0K23.0K8.0K
EBIT(37.7M)(34.8M)(25.5M)(30.1M)(27.0M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026